Sheikh Mohammad Fazle Akbar

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 13

Top Topics

Diffusion Weighted Imaging

Hepatitis B Virus

Immune Response

Top Venues

Journal of gastroenterology

This page only lists publications with an associated author ORCID identifier.

Publications

Mamun Al-Mahtab, Sheikh Mohammad Fazle Akbar, Osamu Yoshida, Julio Cesar Aguilar, Gerardo Guillen, Yoichi Hiasa
Antiviral Response across Genotypes after Treatment of Chronic Hepatitis B Patients with the Therapeutic Vaccine NASVAC or Pegylated Interferon. Vaccines 11 (5) (2023)
Sheikh Mohammad Fazle Akbar, Mamun Al Mahtab, Md Sakirul Islam Khan
Cellular and Molecular Mechanisms of Pathogenic and Protective Immune Responses to SARS-CoV-2 and Implications of COVID-19 Vaccines. Vaccines 11 (3) (2023)
Sheikh Mohammad Fazle Akbar, Mamun A Mahtab, Osamu Yoshida, Julio Aguilar, Guillen Nieto Gerardo, Yoichi Hiasa
Development of Therapy Based on the Exploration of Biological Events Underlying the Pathogenetic Mechanisms of Chronic Hepatitis B Infection. Biomedicines 11 (7) (2023)
Sheikh Mohammad Fazle Akbar, Mamun Al Mahtab, Md Sakirul Islam Khan
Cellular and Molecular Mechanisms of Pathogenic and Protective Immune Responses to SARS-CoV-2 and Implications of COVID-19 Vaccines. Vaccines 11 (3) (2023)
Kana Shiraishi, Osamu Yoshida, Yusuke Imai, Sheikh Mohammad Fazle Akbar, Takahiro Sanada, Michinori Kohara, Takashi Miyazaki, Taizou Kamishita, Teruki Miyake, Masashi Hirooka, Yoshio Tokumoto, Masanori Abe, Julio Cesar Aguilar Rubido, Gerardo Guillen Nieto, Yoichi Hiasa
Intranasal HBsAg/HBcAg-Containing Vaccine Induces Neutralizing Anti-HBs Production in Hepatitis B Vaccine Non-Responders. Vaccines 11 (9) (2023)
Julio Cesar Aguilar, Jorge Agustin Aguiar, Sheikh Mohammad Fazle Akbar
Action Mechanisms and Scientific Rationale of Using Nasal Vaccine (HeberNasvac) for the Treatment of Chronic Hepatitis B. Vaccines 10 (12) (2022)
Julio Cesar Aguilar, Jorge Agustin Aguiar, Sheikh Mohammad Fazle Akbar
Action Mechanisms and Scientific Rationale of Using Nasal Vaccine (HeberNasvac) for the Treatment of Chronic Hepatitis B. Vaccines 10 (12) (2022)
Julio Cesar Aguilar, Jorge Agustin Aguiar, Sheikh Mohammad Fazle Akbar
Action Mechanisms and Scientific Rationale of Using Nasal Vaccine (HeberNasvac) for the Treatment of Chronic Hepatitis B. Vaccines 10 (12) (2022)
Julio Cesar Aguilar, Jorge Agustin Aguiar, Sheikh Mohammad Fazle Akbar
Action Mechanisms and Scientific Rationale of Using Nasal Vaccine (HeberNasvac) for the Treatment of Chronic Hepatitis B. Vaccines 10 (12) (2022)
Sheikh Mohammad Fazle Akbar, Mamun Al Mahtab, Md Sakirul Islam Khan, Osamu Yoshida, Yoichi Hiasa
Development of Therapeutic Vaccine for Chronic Hepatitis B: Concept, Cellular and Molecular Events, Design, Limitation, and Future Projection. Vaccines 10 (10) (2022)
Sheikh Mohammad Fazle Akbar, Mamun Al Mahtab, Md Sakirul Islam Khan, Osamu Yoshida, Julio Cesar Aguilar, Guillen Nieto Gerardo, Yoichi Hiasa
Innovative Therapies Targeting the Virus and the Host for Treating Chronic Hepatitis B Virus Infection: From Bench to Bedside. Vaccines 10 (5) (2022)
Sheikh Mohammad Fazle Akbar, Osamu Yoshida, Yoichi Hiasa
Immune therapies against chronic hepatitis B. Journal of gastroenterology 57 (8) (2022)
Sheikh Mohammad Fazle Akbar, Mamun Al Mahtab, Julio Cesar Aguilar, Osamu Yoshida, Md Sakirul Islam Khan, Eduardo Penton, Guillen Nieto Gerardo, Yoichi Hiasa
The Safety and Efficacy of a Therapeutic Vaccine for Chronic Hepatitis B: A Follow-Up Study of Phase III Clinical Trial. Vaccines 10 (1) (2021)